SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Releases

2016 :: 2015 ::  2014 ::  2013 ::  2012 ::  2011 :: 2010

Freedom® Portable Driver Surpasses 1,200 Days of Patient Life Powering SynCardia's Total Artificial Heart

SynCardia Systems, Inc. announced today that the Freedom® driver, the world's first wearable portable driver for powering the SynCardia temporary Total Artificial Heart both inside and outside the hospital, now accounts for more than 1,200 days of patient life...

Continue Reading

2 European Hospitals Begin Certification to Implant SynCardia's Total Artificial Heart

SynCardia Systems, Inc. announced today that the surgical teams from Ljubljana University Medical Center in Slovenia and Ankara University in Turkey have completed the first phase of certification to implant the SynCardia temporary Total Artificial Heart in Paris. The two hospitals are the 59th and 60th transplant centers worldwide to begin the four-phase certification process...

Continue Reading

SynCardia Co-Founder to Give Keynote Speech at Pumps & Pipes 2010

On Dec. 6, Marvin J. Slepian, M.D., Professor of Medicine (Cardiology and Biomedical Engineering) at the University of Arizona and co-founder and chairman of SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, will be one of three keynote speakers at "Pumps & Pipes 4: No Boundaries," held at the Methodist Hospital Research Institute in Houston. The goal of Pumps & Pipes is to foster and build unique research opportunities between energy and medicine – Houston's largest industries - to enhance and develop resources and technologies...

Continue Reading

Oklahoma Pastor Gives 1st Sermon Since Receiving SynCardia's Total Artificial Heart

Before heart failure stopped him in his tracks, 45-year-old Troy Golden had preached every Sunday for the last 12 years at the New Life Assembly of God in Geary, OK. Too sick to preach for the last six months, on Sunday, Nov. 21, Golden gave his first sermon since receiving the SynCardia temporary Total Artificial Heart and being discharged home using the Freedom® portable driver...

Continue Reading

University Hospital of Nantes Presents 18-Year Experience with SynCardia's Total Artificial Heart

On Oct. 17, Dr. Jean Christian Roussel from the Thorax Institute at University Hospital of Nantes presented the center's 18-year experience with the SynCardia temporary Total Artificial Heart at the Acute Cardiac Care 2010 medical meeting in Copenhagen, Denmark. The aim of the single center, retrospective study was to assess both the comorbidity and survival of patients awaiting heart transplants while supported by SynCardia's Total Artificial Heart...

Continue Reading

SynCardia Science Advisory Board Experts Awarded $7.5 Million Grant to Optimize Designs of Cardiovascular Devices

On Nov. 4, SynCardia Systems, Inc., announced that three of its Science Advisory Board experts have been awarded a five-year, $7.5 million grant from the National Institutes of Health (NIH) entitled "Optimizing Cardiovascular Device Thromboresistance for Eliminating Anticoagulants"...

Continue Reading

2 U.S. Hospitals Begin Certification to Implant Total Artificial Heart

SynCardia Systems, Inc. announced today that Brigham and Women's Hospital in Boston, and University of Iowa (UI) Hospitals and Clinics in Iowa City, Iowa, have begun certification to implant the SynCardia temporary Total Artificial Heart. Brigham and Women's will complete Phase I of certification on Nov. 1 & 2, and UI Hospitals and Clinics completed Phase I on Oct. 21 & 22...

Continue Reading

2nd Total Artificial Heart Patient in U.S. History Discharged from the Hospital Using the Freedom® Portable Driver

On Oct. 18, 45-year-old Troy Golden became the second patient in the U.S. to leave the hospital using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart. The pastor from Geary, Okla. was discharged from INTEGRIS Baptist Medical Center to wait for a matching donor heart at home with his family and friends...

Continue Reading

SynCardia's Total Artificial Heart Featured Among 100 Most Important Events in Human History

On Oct. 23, a new exhibit featuring the SynCardia temporary Total Artificial Heart titled "From the Big Bang to the World Wide Web: The Origins of Everything," will open at the Mathers Museum of World Cultures at Indiana University (IU). The exhibit revolves around the 100 most important events in the "evolution of everything," including human, biological and planetary history...

Continue Reading

Ege University Hospital Implants Turkey's 1st Total Artificial Heart

On Sept. 30, Ege University Hospital in Izmir performed Turkey's first implant of the SynCardia temporary Total Artificial Heart. The surgery was led by Prof. Dr. Mustafa Ozbaran, head of the Transplant and Assist Device Program, and proctored by experienced Total Artificial Heart surgeon Dr. Latif Arusoglu...

Continue Reading

UCSD Medical Center to Begin Certification for Total Artificial Heart

SynCardia Systems, Inc. announced today that the University of California, San Diego (UCSD), led by Stuart W. Jamieson, M.B., F.R.C.S., Head of Cardiothoracic Surgery, will begin certification to implant the SynCardia temporary Total Artificial Heart. Efforts to bring the Total Artificial Heart to UCSD were led by world renowned heart surgeon, Dr. Jack Copeland, who joined the faculty in July...

Continue Reading

Italian Man Surpasses 1,000 Days of Support with SynCardia's Total Artificial Heart

A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with the SynCardia temporary Total Artificial Heart while waiting for a matching donor heart...

Continue Reading

1st Northwest Hospital Begins Certification Program to Implant the World's Only Approved Total Artificial Heart

On Oct. 4 & 5, the surgical team from Sacred Heart Medical Center, one of the largest hospitals in the Northwest, led by Timothy B. Icenogle, M.D., Director of the Mechanical Heart Program, completed the first phase of certification to implant the SynCardia temporary Total Artificial Heart. Sacred Heart is scheduled to complete Phase II of certification on Oct. 12 & 13, followed by the proctored first implant after an appropriate patient has been identified...

Continue Reading

Oklahoma Man 1st in Region to Receive Total Artificial Heart

On Sept. 15, 45-year-old Troy Golden of Geary, Okla., became the first person in the region to have his heart replaced with the SynCardia temporary Total Artificial Heart at INTEGRIS Baptist Medical Center in Oklahoma City. It is a distinction that was years in the making....

Continue Reading

SynCardia Total Artificial Heart Wins Australian Award for Excellence in Medical Technology

On Sept. 15, the SynCardia temporary Total Artificial Heart was awarded the 2010 Kerrin Rennie Award for Excellence in Medical Technology by the Medical Technology Association of Australia (MTAA). The award was presented to SynCardia's Australian distributor Device Technologies during the MTAA annual conference. Device Technologies is a major supplier of leading edge medical equipment and consumables to hospitals and healthcare professionals throughout Australia and New Zealand. Device Technologies is a major supplier of leading edge medical equipment and consumables to hospitals and healthcare professionals throughout Australia and New Zealand...

Continue Reading

St. Vincent’s Hospital Implants Australia’s First Total Artificial Heart

On Aug. 5, St. Vincent’s Hospital in Sydney performed Australia’s first implant of the SynCardia temporary Total Artificial Heart. The patient, a 50-year-old-male suffering from total heart failure, is the first recipient of the Total Artificial Heart in the Southern Hemisphere. The surgery was performed by heart surgeons Drs. Phillip Spratt and Paul Jansz...

Continue Reading

Methodist DeBakey Heart & Vascular Center Begins Certification Training for World’s Only Approved Total Artificial Heart

On July 8 & 9, the 13-member surgical team from the Methodist DeBakey Heart & Vascular Center in Houston, led by Dr. Matthias Loebe, Surgical Director of the Heart & Lung Transplant Program, completed the first phase of certification training to implant the SynCardia temporary Total Artificial Heart...

Continue Reading

Michael Garippa Joins SynCardia as President

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Michael Garippa, the CEO and President of TandemHeart for the last 8 years, has left the company to become SynCardia’s new president. Rodger Ford will continue as SynCardia’s CEO, concentrating on business development, while Mr. Garippa focuses on sales, clinical support, training and marketing...

Continue Reading

World Renowned Total Artificial Heart Pioneer Dr. Jack Copeland Joins Faculty at UC San Diego

On July 1, Total Artificial Heart pioneer and world renowned heart surgeon, Dr. Jack Copeland, will join the faculty at the new $227 million Sulpizio Family Cardiovascular Center at the University of California, San Diego in La Jolla...

Continue Reading

World’s 1st Total Artificial Heart Patients Discharged Home Using SynCardia’s Freedom® Portable Driver

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the world’s first three Total Artificial Heart patients have been discharged from SynCardia Certified Centers using the new Freedom® portable driver. Weighing 13.5 lbs, the Freedom driver is the world’s first wearable portable driver designed to power SynCardia’s Total Artificial Heart both inside and outside the hospital....

Continue Reading

SynCardia Named Among Top 50 Companies to Watch by Medical Device and Diagnostic Industry Magazine

Medical Device and Diagnostic Industry (MD+DI) magazine has selected SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, as one of 50 Companies to Watch for 2010...

Continue Reading

1st SynCardia Total Artificial Heart Patient in U.S. History Discharged with Freedom® Portable Driver

On May 3, a Phoenix-area SynCardia Certified Center became the first hospital in U.S. history to discharge a patient implanted with the SynCardia temporary Total Artificial Heart to wait at home for a matching donor heart. This hospital is participating in an FDA Investigational Device Exemption (IDE) clinical study of the Freedom® driver, the first ever U.S. portable driver designed to power SynCardia’s Total Artificial Heart both inside and outside the hospital...

Continue Reading

Rapid Onset of Acquired von Willebrand Syndrome Observed with Ventricular Assist Devices, Not SynCardia Total Artificial Heart

The findings of a 12 patient study recently published in Thrombosis and Haemostasis by University Medical Center Freiburg documented that patients implanted with a ventricular assist device (VAD) experienced a rapid onset of acquired von Willebrand syndrome (AVWS), while patients implanted with the SynCardia temporary Total Artificial Heart did not. The lead author of the study was Dr. Claudia Heilmann, Head of the Research Department for the Department of Heart and Vascular Surgery at University Medical Center Freiburg...

Continue Reading

CHRU Tours Performs 1st Implant of SynCardia’s Total Artificial Heart

On April 1, Centre Hospitalier Universitaire et Régional de Tours (CHRU Tours) in France, led by Prof. Michel R. Aupart, performed its first implant of the SynCardia temporary Total Artificial Heart into a 44-year-old male with ischemic heart disease who had suffered a heart attack that caused both sides of his heart to fail...

Continue Reading

1st Hospital in Greece Begins Certification Training to Implant SynCardia’s Total Artificial Heart

On March 4 & 5, the surgical team from the Onassis Cardiac Surgery Center, led by Dr. Petros Sfirakis, Director of the Transplantation Department & Mechanical Support Unit and Dr. Louis Louca, Surgeon/VAD Coordinator, completed the first phase of certification training to implant the SynCardia temporary CardioWest™ Total Artificial Heart...

Continue Reading

Freedom® Driver System Receives CE Mark to Power SynCardia’s Total Artificial Heart in Europe

On March 4, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced that its new Freedom® driver system has received the CE Mark to power the Total Artificial Heart in Europe...

Continue Reading

Dr. Marvin Slepian Gives Keynote Speech on SynCardia’s Total Artificial Heart at Medical Devices Summit 2010

On March 2, Dr. Marvin Slepian, world-renowned interventional cardiologist and co-founder and chairman of SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, was the keynote speaker at the Medical Devices Summit 2010 held in Boston...

Continue Reading

Belgian Hospital 50th Transplant Center to Begin Certification Training to Implant SynCardia’s Total Artificial Heart

On Feb. 25 & 26, the surgical team from Onze Lieve Vrouw (OLV) Hospital Aalst, led by surgeons Ivo Deblier, MD, and Karl Dossche, PhD, and accompanied by anesthesiologist Koen De Decker, MD, will become the first hospital in Belgium and the 50th hospital in the world to complete the first phase of certification training to implant the SynCardia temporary CardioWest™ Total Artificial Heart...

Continue Reading

La Pitié Hospital Performs its 200th Implant of the World’s Only Approved Total Artificial Heart

On Feb. 18, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced that Groupe hospitalier de la Pitié-Salpétrière (La Pitié) in Paris has performed 200 implants of the Total Artificial Heart, more than any other hospital in the world...

Continue Reading

Total Artificial Heart Recipient Celebrates 10 Years of Life with Donor Heart

On Feb. 22, Bill Wohl, a former recipient of the SynCardia temporary CardioWest™ Total Artificial Heart, will celebrate 10 years of enjoying life to the fullest with the donor heart he received at University Medical Center on Feb. 22, 2000...

Continue Reading

Leading Expert in Hemodynamics Aims to Use New Emulator Technology to Eliminate Blood Clotting in Cardiovascular Devices

On Jan. 22, Danny Bluestein, PhD, Professor of Bioengineering at the State University of New York (SUNY) Stony Brook, in collaboration with Marvin J. Slepian, M.D., Professor of Medicine (Cardiology) at the University of Arizona, submitted a Phase II Quantum Grant proposal to the National Institute of Biomedical Imaging and Bioengineering (NIBIB)...

Continue Reading

3 New Centers Begin Certification Training to Implant SynCardia’s Total Artificial Heart

On Feb. 1 and 2, surgical teams from Turkiye Yuksek Ihtisas Hospital in Ankara, Turkey, Yeditepe University Hospital in Istanbul and University Hospital of Bordeaux in France, completed the first phase of certification training in Paris to implant the SynCardia temporary CardioWest™ Total Artificial Heart...

Continue Reading

German Man Bridged-to-Transplant After 615 Days of Life with SynCardia’s Total Artificial Heart

Bobby Dhawan, 51, is the owner of a successful taxi service in Germany. Normally, he does not allow bumper stickers to be placed on his cabs, but recently, he made a special exception for a sticker which reads, “Don’t take your organs to heaven - heaven knows we need them here!”...

Continue Reading

Successful Artificial Heart Pursued by Many, Achieved by One

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, has announced the launch of its new website to educate visitors that the artificial heart isn’t science fiction: it’s real, it works and it’s saving lives...

Continue Reading

Search offcanvas